These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 3181666
1. Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test. Adachi Y, Nanno T, Itoh T, Kurumi Y, Yamazaki K, Sawada Y, Yamamoto T. Gastroenterol Jpn; 1988 Aug; 23(4):401-7. PubMed ID: 3181666 [Abstract] [Full Text] [Related]
2. [Application of high resolution liquid chromatography to the test of bile acid tolerance]. Marotta F, Hashimoto L, Safran P. G Clin Med; 1990 Jan; 71(1):31-6. PubMed ID: 2365167 [Abstract] [Full Text] [Related]
3. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome. Zhou K, Wang J, Xie G, Zhou Y, Yan W, Pan W, Che Y, Zhang T, Wong L, Kwee S, Xiao Y, Wen J, Cai W, Jia W. J Proteome Res; 2015 Nov 06; 14(11):4844-50. PubMed ID: 26449593 [Abstract] [Full Text] [Related]
4. Clinical significance of serum bile acid measurement in liver diseases. Morita T, Matsuyama Y, Fujimoto T, Higuchi M, Tsujii T, Matsuoka Y. Gastroenterol Jpn; 1978 Nov 06; 13(6):491-502. PubMed ID: 748093 [Abstract] [Full Text] [Related]
5. Fasting and postprandial serum bile acids as a screening test for hepatocellular disease. Angelico M, Attili AF, Capocaccia L. Am J Dig Dis; 1977 Nov 06; 22(11):941-6. PubMed ID: 920703 [Abstract] [Full Text] [Related]
6. [The importance of the analysis of serum bile acids in chronic liver diseases]. Ungár P, Orbán E, Bély M, Kocsár L, Romics L. Orv Hetil; 1986 Mar 30; 127(13):755-9. PubMed ID: 3703540 [No Abstract] [Full Text] [Related]
7. [Radioimmunoassay of cholylglycine in serum (author's transl)]. Wakushima T, Yamanishi Y, Hirayama C. Radioisotopes; 1979 Jul 30; 28(7):437-40. PubMed ID: 504726 [Abstract] [Full Text] [Related]
8. Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans. Luo L, Aubrecht J, Li D, Warner RL, Johnson KJ, Kenny J, Colangelo JL. PLoS One; 2018 Jul 30; 13(3):e0193824. PubMed ID: 29513725 [Abstract] [Full Text] [Related]
9. [Clinical examination of serum bile acids for the diagnosis of hepatobiliary diseases]. Fujiwara K. Rinsho Byori; 1989 Oct 30; 37(10):1114-21. PubMed ID: 2601071 [Abstract] [Full Text] [Related]
10. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH. J Gastroenterol Hepatol; 1996 Mar 30; 11(3):208-15. PubMed ID: 8742915 [Abstract] [Full Text] [Related]
11. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thörne A, Nowak G, Ericzon BG, Björkhem I, Einarsson C. Hepatology; 2003 Oct 30; 38(4):930-8. PubMed ID: 14512880 [Abstract] [Full Text] [Related]
12. Measurement of sulfated and nonsulfated bile acids in human serum and urine. Makino I, Shinozaki K, Nakagawa S, Mashimo K. J Lipid Res; 1974 Mar 30; 15(2):132-8. PubMed ID: 4832755 [Abstract] [Full Text] [Related]
14. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y, Yao C, Jia W, Liu P. J Proteome Res; 2016 Apr 01; 15(4):1126-34. PubMed ID: 25964117 [Abstract] [Full Text] [Related]
19. Clinical usefulness of serum cholylglycine determination in various liver diseases. Tanggo Y, Fujiyama S, Kin F, Tashiro A, Shiraoku H, Akahoshi M, Sato Y, Hashiguchi O, Sagara K. Gastroenterol Jpn; 1982 Oct 01; 17(5):447-52. PubMed ID: 7173571 [Abstract] [Full Text] [Related]